Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction : the modifying role of obesity
![Thumbnail](/xmlui/bitstream/handle/10234/208161/90217_DominguezMafeE_2024.pdf.jpg?sequence=5&isAllowed=y)
View/ Open
Impact
![Google Scholar](/xmlui/themes/Mirage2/images/uji/logo_google.png)
![Microsoft Academico](/xmlui/themes/Mirage2/images/uji/logo_microsoft.png)
Metadata
Show full item recordcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONMetadata
Title
Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction : the modifying role of obesityAuthor (s)
Date
2024-06-12Publisher
Elsevier ScienceDirectISSN
1871-403X; 1878-0318Bibliographic citation
Palau, P., Núñez, G., de la Espriella, R., Miñana, G., Domínguez, E., Lorenzo, M., Lopez, L., Flor, C., Marin, P., Bayés, A., Sanchis J. & Núñez, J. (2024). Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction: The modifying role of obesity. Obesity Research & Clinical Practice.Type
info:eu-repo/semantics/articleVersion
info:eu-repo/semantics/publishedVersionSubject
Abstract
This study investigates the association between maximal functional capacity (peakVO2) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in 133 ambulatory patients with heart failure with preserved ejection ... [+]
This study investigates the association between maximal functional capacity (peakVO2) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in 133 ambulatory patients with heart failure with preserved ejection fraction (HFpEF), focusing on patients with obesity. Across all participants, NT-proBNP inversely correlated with peakVO2. However, this association varied based on obesity status. In patients without obesity, there was an inverse relationship between NT-proBNP and peakVO2, while no significant correlation was observed in patients with obesity. These findings suggest that in stable ambulatory HFpEF, NT-proBNP did not predict peakVO2 in patients with obesity. [-]
Is part of
Obesity Research & Clinical Practice, Vol. 18, Issue 3 (May-June 2024)Funder Name
Ministerio de Economía y Competitividad / Instituto de Salud Carlos III | European Regional Development Fund (ERDF)
Project code
PI17/01426 | 16/11/00420 | 16/11/00403
Rights
info:eu-repo/semantics/openAccess
This item appears in the folowing collection(s)
- MED_Articles [667]